---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

## Published

**McGovern A**, Chapple AG, Ma C. (2022). [“2S-Sub-TITE: An adaptive two-stage time-to
toxicity model for subgroup-specific dose finding.”](files/Pharm_Stat_Paper.pdf) Pharmaceutical Statistics, 21. 6.

Carpenter K, Scavotto M, **McGovern A**, Ma C, Kenney LB, Mack JW, Greenzang KA. (2021).
[“Early Parental Knowledge of Late Effect Risks in Children with Cancer.”](https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.29473) Pediatric
Blood Cancer, e29335. 

Umaretiya PJ, Li A, **McGovern A**, Ma C, Wolfe J, Bona K. (2021). [“Race, ethnicity, and
goal-concordance of end-of-life palliative care in pediatric oncology.”](https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33768) Cancer, 127.
20. 

Lim-Fat MJ, Vogelzang J, Woodward E, **McGovern A**, Ma C, Al-Sayegh H, Alexandrescu S,
Margol A, Cotter J, Cole K, Li M, Owens E, Smith A, Goldman S, Kaneva K, Burton
E, Nazemi K, Wright K, Wen P, Warren K, Touat M, Reardon D, Bi WL, Ligon K,
Yeo KK. (2020). “A multi institutional comparative analysis of the clinical, genomic,
and survival characteristics of pediatric, young adult and older adult patients with IDH
mutant glioma.” Neuro-Oncology, 22. 2.


## Submitted

**McGovern A**, Wilson K, Wakefield J. [“Direct-Assisted Bayesian Unit-level Modeling for Small Area
Estimation of Rare Event Prevalence.”](https://arxiv.org/abs/2408.16129) 
